- Home
- INSM vs PPL Comparison
INSM vs PPL Comparison
Compare INSM & PPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSM
- PPL
- Stock Information
- Founded
- INSM 1988
- PPL 1920
- Country
- INSM United States
- PPL United States
- Employees
- INSM N/A
- PPL N/A
- Industry
- INSM Biotechnology: Pharmaceutical Preparations
- PPL Electric Utilities: Central
- Sector
- INSM Health Care
- PPL Utilities
- Exchange
- INSM Nasdaq
- PPL Nasdaq
- Market Cap
- INSM 26.0B
- PPL 25.4B
- IPO Year
- INSM 2000
- PPL N/A
- Fundamental
- Price
- INSM $127.80
- PPL $36.54
- Analyst Decision
- INSM Strong Buy
- PPL Buy
- Analyst Count
- INSM 17
- PPL 10
- Target Price
- INSM $137.40
- PPL $36.70
- AVG Volume (30 Days)
- INSM 3.0M
- PPL 7.3M
- Earning Date
- INSM 08-07-2025
- PPL 07-31-2025
- Dividend Yield
- INSM N/A
- PPL 2.98%
- EPS Growth
- INSM N/A
- PPL 17.72
- EPS
- INSM N/A
- PPL 1.33
- Revenue
- INSM $398,105,000.00
- PPL $8,806,000,000.00
- Revenue This Year
- INSM $28.23
- PPL $5.13
- Revenue Next Year
- INSM $119.99
- PPL $4.00
- P/E Ratio
- INSM N/A
- PPL $27.47
- Revenue Growth
- INSM 21.15
- PPL 6.62
- 52 Week Low
- INSM $60.40
- PPL $30.76
- 52 Week High
- INSM $128.48
- PPL $37.31
- Technical
- Relative Strength Index (RSI)
- INSM 85.01
- PPL 56.92
- Support Level
- INSM $106.54
- PPL $36.08
- Resistance Level
- INSM $128.48
- PPL $37.31
- Average True Range (ATR)
- INSM 4.11
- PPL 0.57
- MACD
- INSM 1.68
- PPL 0.02
- Stochastic Oscillator
- INSM 97.41
- PPL 61.50
About INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
About PPL PPL Corporation
PPL is a holding company of regulated utilities in Pennsylvania, Kentucky, and Rhode Island. The Pennsylvania regulated delivery and transmission segment distributes electricity to customers in central and eastern Pennsylvania. In Kentucky, LG&E and KU are involved in regulated electricity generation, transmission, and distribution. LG&E also provides regulated natural gas distribution. Rhode Island Energy operates electric and gas utilities in the state.